Meiji Seika Pharma Co., Ltd.   Report issue

Founded: Tokyo Japan (1916)
Status: No NME R&D (1916)

Organization Overview

First Clinical Trial
2010
NCT01142596
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Meiji Co., Ltd. | Meiji Pharma Spain S.A. | Meiji Seika Pharma Co., Ltd.